“Johns Hopkins is deeply committed to exploring innovative treatments for our patients. Our scientists have shown that psychedelics have real potential as medicine, and this new center will help us explore that potential.”
– Paul B. Rothman, M.D., Dean of the Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine.
John Hopkins leads the research on the positive effects of entheogens like LSD, MDMA, and psilocybin (magic mushrooms). The Johns Hopkins Center for Psychedelic & Consciousness Research received governing approval from the United States government in early 2000. They now have over 60 peer-reviewed research papers.
The U.S. government still has psilocybin classified as a Schedule I drug, meaning it has no medical uses and has a high risk for abuse. Nevertheless, psychedelics’ stigma is being treated differently, and people’s outlook on them is changing quickly.
Just last year, in 2020, the state of Oregon passed a bill and legalized psilocybin. John Hopkin’s researchers have shown the therapeutic effects of people who suffer from anxiety, depression, addiction, and end-of-life therapy caused by a terminal illness or old age.
The UFC, the primary funder of a pro athlete brain study being done by the Cleveland Clinic Lou Ruvo Center for Brain Health, recently donated another $1 million. The UFC is recruiting current and past fighters to be apart of these studies for the Lou Ruvo Center and John Hopkins.
The UFC fighters that are being part of these studies are looking into doing microdosing. Microdosing is where a doctor will take a drug being studied and administer small amounts low enough to have full-body effects most likely, but sufficient quantity to provide a cellular response to be studied.
Psilocybin mushrooms have been shown to produce neurogenesis – the growth of new brain cells. It will be interesting to see if the damaged brain cells in fighters can be revered or replaced by new ones by taking psilocybin. It also would help fighters dealing with anxiety, depression, addiction, anger and other symptoms associated with brain damage.